coronavirus
newli
discov
viru
wuhan
china
virus
caus
sar
mer
result
region
global
public
health
emerg
base
molecular
insight
hepat
c
viru
coronaviru
use
similar
viral
genom
replic
mechan
reason
fdaapprov
drug
epclusa
sofosbuvirvelpatasvir
treatment
hepat
c
also
inhibit
coronavirus
includ
develop
broad
spectrum
antivir
agent
describ
novel
strategi
design
synthes
viral
polymeras
inhibitor
combin
protid
prodrug
approach
use
develop
sofosbuvir
use
group
previous
built
nucleotid
analogu
function
polymeras
termin
virusbas
hostbas
treatment
option
target
coronaviru
replic
cycl
zumla
et
al
nat
rev
drug
discoveri
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
one
import
druggabl
target
rdrp
exampl
drug
includ
gilead
sofosbuvir
pair
velpatasvir
fdaapprov
drug
epclusa
inhibit
rnadepend
rna
polymeras
hepat
c
viru
sofosbuvir
pyrimidin
nucleotid
analogu
fig
block
phosphat
group
enabl
enter
infect
eukaryot
cell
prodrug
convert
activ
triphosph
form
cellular
enzym
fig
activ
drug
bind
activ
site
rdrp
incorpor
rna
due
modif
posit
inhibit
rna
chain
extens
halt
rna
replic
act
rna
polymeras
inhibitor
compet
natur
ribonucleotid
base
insight
hepat
c
viru
coronaviru
use
similar
viral
genom
replic
mechan
reason
fdaapprov
drug
epclusa
treatment
hepat
c
also
inhibit
coronavirus
includ
respons
sar
mer
mani
rna
polymeras
inhibitor
drug
use
antivir
relat
purin
nucleotid
prodrug
remdesivir
fig
develop
gilead
treat
ebola
viru
infect
though
success
current
consid
reposit
treat
outbreak
http
wwwfiercebiotechcombiotechgileadmullsrepositioningfailedeboladrugchinaviru
contrast
sofosbuvir
group
unmodifi
cyano
group
posit
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
presum
serv
inhibit
rdrp
activ
triphosph
form
addit
inform
protid
prodrug
technolog
describ
alanazi
et
al
relat
prodrug
analogu
develop
biocryst
pharmaceut
also
known
galidesivir
fig
shown
inhibit
rna
polymeras
broad
spectrum
rna
virus
notabl
includ
filovirus
eg
ebola
marburg
rodent
marburg
viru
macaqu
warren
et
al
upon
entri
infect
cell
rapidli
phosphoryl
result
nucleosid
triphosph
serv
rna
chain
termin
base
background
inform
describ
novel
strategi
design
synthes
viral
polymeras
inhibitor
combin
protid
prodrug
approach
use
develop
sofosbuvir
use
group
built
nucleotid
analogu
function
revers
termin
dna
sequenc
ju
et
al
ju
et
al
guo
et
al
reason
phosphat
mask
group
allow
entri
compound
infect
cell
group
either
free
modif
posit
encourag
incorpor
activ
triphosph
analogu
viral
polymeras
host
cell
polymeras
thu
reduc
side
effect
incorpor
extens
prevent
virtu
group
therebi
inhibit
viral
replic
modifi
nucleotid
analogu
potent
polymeras
inhibitor
thu
activ
variou
viral
diseas
includ
limit
coronavirus
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
strain
caus
sar
mer
incorpor
newli
design
nucleotid
analogu
contain
block
group
perman
block
viral
genom
replic
contrast
nucleotid
analoguebas
viral
inhibitor
free
oh
group
possibl
allow
polymeras
extens
enabl
viral
mutat
reason
high
concentr
nucleotid
analoguebas
viral
inhibitor
free
oh
group
potenti
incorpor
host
polymeras
rna
virus
known
mutat
high
frequenc
due
low
fidel
viral
polymeras
result
develop
resist
treatment
promiscu
natur
viral
polymeras
allow
incorpor
newli
design
nucleotid
analogu
antivir
agent
exampl
nucleotid
analogu
design
us
satisfi
criteria
provid
fig
strategi
synthesi
fig
fig
show
activ
prodrug
form
triphosph
analogu
sofosbuvir
fig
incorpor
inhibit
coronaviru
rna
viru
polymeras
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
copyright
holder
preprint
peerreview
http
synthesi
nucleosid
phosphoramid
prodrug
carri
start
nucleosid
ross
et
al
first
exocycl
amino
group
base
protect
derivat
varieti
block
group
includ
methyl
ethyl
propyl
allyl
propargyl
methoxymethyl
methylthiomethyl
azidomethyl
etc
list
follow
establish
method
ju
et
al
guo
et
al
deprotect
free
derivat
afford
correspond
phosphoramid
treatment
freshli
prepar
chlorophosphoramid
reagent
presenc
nmethyl
imidazol
sofia
et
al
fig
fig
show
exampl
synthet
rout
nucleosid
phosphoramid
analog
respect
altern
start
nucleosid
derivat
first
give
nucleotid
follow
derivat
afford
block
nucleosid
phosphoramid
analogu
fig
show
exampl
synthet
rout
nucleosid
phosphoramid
analogu
acknowledg
research
support
columbia
univers
file
patent
applic
work
describ
manuscript
ccbyncnd
intern
licens
authorfund
made
avail
copyright
holder
preprint
peerreview
http
doi
biorxiv
preprint
